RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.

David BusquetsLia OliverJoan AmoedoSara Ramió-PujolMarta MalagónMarta SerranoAnna BahíMontse CapdevilaAleix LluansíLeyanira TorrealbaLaia PeriesRosa ChaveroPau GilabertMiriam SàbatJordi GuardiolaMariona Serra-PagèsJesús Garcia-GilXavier Aldeguer

Published in: Inflammatory bowel diseases (2021)

A specific bacterial signature could beneficiate patients with inflammatory bowel disease predicting the therapeutic effectiveness of an anti-TNF treatment, leading to a personalized therapy, improving the patients' quality of life, saving costs and gaining time in patient improvement.

Keyphrases

rheumatoid arthritis
patients with inflammatory bowel disease
end stage renal disease
systematic review
randomized controlled trial
ejection fraction
newly diagnosed
prognostic factors
bone marrow
mesenchymal stem cells
patient reported outcomes
replacement therapy